Literature DB >> 6573872

Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis.

R D Armstrong, G S Panayi, K I Welsh.   

Abstract

Patients with ankylosing spondylitis, psoriatic arthritis, and psoriasis alone were typed for HLA A, B, Cw, and DR antigens, and the antigen frequencies were compared with those in a normal control population and in patients with rheumatoid arthritis. Patients with psoriasis had a significantly raised frequency of Cw6. Those with arthritis in addition to their psoriasis also had raised frequencies of B27 and DR7. Patients with ankylosing spondylitis were characterised by the expected high frequency of HLA B27. Again, those with peripheral arthritis had a higher B27 and DR7 frequency than those without. DR3 is associated with the development of erosions in psoriatic arthritis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6573872      PMCID: PMC1001087          DOI: 10.1136/ard.42.2.142

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  HL-A W27 in psoriatic arthropathy.

Authors:  A L Metzger; R I Morris; R Bluestone; P I Terasaki
Journal:  Arthritis Rheum       Date:  1975 Mar-Apr

Review 2.  Psoriatic arthritis.

Authors:  J M Moll; V Wright
Journal:  Semin Arthritis Rheum       Date:  1973       Impact factor: 5.532

3.  HL-A antigens in psoriatic arthritis.

Authors:  J Karvonen; A Lassus; U Sievers; A Tiilikainen
Journal:  Ann Clin Res       Date:  1974-10

4.  HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis.

Authors:  D A Brewerton; M Caffrey; A Nicholls; D Walters; D C James
Journal:  Lancet       Date:  1974-05-18       Impact factor: 79.321

5.  Ankylosing spondylitis and HL-A 27.

Authors:  D A Brewerton; F D Hart; A Nicholls; M Caffrey; D C James; R D Sturrock
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

6.  HL-A antigen in psoriasis.

Authors:  L S Krain; V D Newcomer; P I Terasaki
Journal:  N Engl J Med       Date:  1973-06-07       Impact factor: 91.245

7.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

8.  Disturbance of HL-A antigen frequency in Psoriasis.

Authors:  S H White; V D Newcomer; M R Mickey; P I Terasaki
Journal:  N Engl J Med       Date:  1972-10-12       Impact factor: 91.245

9.  Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex.

Authors:  C Murray; D L Mann; L N Gerber; W Barth; S Perlmann; J L Decker; T P Nigra
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

10.  The HLA system and disease. The Oliver Sharpey Lecture 1979.

Authors:  W F Bodmer
Journal:  J R Coll Physicians Lond       Date:  1980-01
View more
  24 in total

Review 1.  Immune functions and inflammatory reactions in HLA-B27 positive subjects.

Authors:  R Tertti; P Toivanen
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

2.  Clinical and immunogenetic characterization in psoriatic arthritis patients.

Authors:  Emilce Edith Schneeberger; Gustavo Citera; Gustavo Rodríguez Gil; Amelia Granel; Alfredo Arturi; Gabriel Marcos Rosemffet; José Antonio Maldonado Cocco; Alberto Berman; Alberto Spindler; Victor Hugo Morales
Journal:  Clin Rheumatol       Date:  2014-07-11       Impact factor: 2.980

Review 3.  B27 positive diseases versus B27 negative diseases.

Authors:  A Linssen; T E Feltkamp
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

Review 4.  Juvenile chronic arthritis--clinical sub-groups with particular relationship to adult patterns of disease.

Authors:  R C Allen; B M Ansell
Journal:  Postgrad Med J       Date:  1986-09       Impact factor: 2.401

5.  HLA-DR4 in ankylosing spondylitis with different patterns of joint involvement.

Authors:  W Miehle; M Schattenkirchner; D Albert; M Bunge
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

6.  Osteoarticular manifestations of pustulosis palmaris et plantaris and of psoriasis: two distinct entities.

Authors:  O Mejjad; A Daragon; J P Louvel; L F Da Silva; E Thomine; P Lauret; X Le Loët
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

7.  Immunoglobulin allotype Gm(1,2;21) in ankylosing spondylitis with peripheral arthritis.

Authors:  R Mierau; C A von Mühlen; H Zarnowski; E Genth; P W Hartl
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

8.  Plasma fibronectin in psoriatic arthritis subgroups.

Authors:  M Cutolo; S Accardo; M A Cimmino; S Rovida
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

9.  Natural killer cell activity in inflammatory joint disease.

Authors:  R D Armstrong; G S Panayi
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

10.  HLA antigens in psoriasis and psoriatic arthritis.

Authors:  J C Woodrow; A Ilchysyn
Journal:  J Med Genet       Date:  1985-12       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.